Generieke Naam |
Kenyteken Naam / Alternatiewe Naam |
Uitdruksstelsel |
Vervaardiger |
Ondernaveldigingsfase |
Menslike Insuline, Rekombinant |
Novolin R, NN-729, Novolin R, Actrapid, Velosulin BR, 诺和灵, ヒトインスリン(遺伝子組換え) |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Menslike Insulien Isofaan |
Novolin N, Insulatard, Protaphane |
Ja t (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Menslike insulien, sink suspensie |
Monotard, Ultratard |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Insulin aspart |
NovoLog, NovoRapid, Fiasp, 诺和锐 |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
insulin aspart protamine + insulin aspart |
Fase-insulin aspart, NovoMix, NovoLog Mix 50/50, 70/30 |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
insulin degludec |
Tresiba, IDeg, 诺和达, トレシーバ |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Insulin degludec+Liraglutide |
IDegLira, Tresiba, Insulin degludec/Victoza, 诺和益, ゾルトファイ |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Insulien detemir |
Levemir, レベミル, 诺和平 |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Insulin Degludec+Insulin Aspart |
DegludecPlus, Ryzodeg 70/30, IDegAsp, NN1045,诺和佳 |
Heuninggist (Saccharomyces cerevisiae)
|
Novo Nordisk |
Goedkeuring |
Recombinant menslike insulien |
Humulin R, Youweilin |
Escherichia coli (E. coli) |
Eli Lilly, Genentech |
Goedkeuring |
Menslike Insulien Isofaan |
Humulin N |
Escherichia coli (E. coli) |
Eli Lilly |
Goedkeuring |
Lispro Insulien |
Humalog, Liprolog, 优泌乐, ルムジェブ |
Escherichia coli (E. coli) |
Eli Lilly |
Goedkeuring |
lispro+protamine insuline |
Humalog Mix, Liprolog Mix, 优泌乐 |
Escherichia coli (E. coli) |
Eli Lilly |
Goedkeuring |
Glargine Insuline |
Basagla, Rezvoglar, Abasaglar, インスリン グラルギン(遺伝子組換え) |
Escherichia coli (E. coli) |
Eli Lilly |
Goedkeuring |
Recombinant menslike insulien |
Afrezza, Insuman |
Escherichia coli (E. coli) |
Sanofi |
Goedkeuring |
Insuline lispro |
Admelog, SAR342434 |
Escherichia coli (E. coli) |
Sanofi |
Goedkeuring |
Insulin Glargine |
Lantus, Toujeo, 来得时 |
Escherichia coli (E. coli) |
Sanofi |
Goedkeuring |
Insuline Glargine+Lixisenatide |
Suliqua 100/33, Glargine-Insulin-rekombinatie, Sintese van Lixisenatide |
N.a. |
Sanofi, Genzyme, Zealand Pharma |
Goedkeuring |
insulin glulisine |
Apidra |
Escherichia coli (E. coli) |
Sanofi, LifeScan |
Goedkeuring |
Menslike isofane insulien |
Rinsulin Mix 30/70, Rinsulin NPH |
Wag opdate |
Geropharm |
Goedkeuring |
Insulin Glargine |
Lusduna |
Escherichia coli (E. coli) |
Merck |
Goedkeuring, Getrekken |
Insulin aspart |
Wag opdate |
Wag opdate |
Geropharm |
Goedkeuring |
Insulien menslike inhaalpoeder |
Afresa, Afrezza, Insulien, Insulien menslik, Insulien menslik (inhalasiepoeder), Insulien inhaal, Technosphere Insulien, SAR-439065, Technosphere Insulienstelsel |
E. coli (K12) |
MannKind Corporation, Sanofi |
Goedkeuring |
Glargine Insuline |
Wag opdate |
Wag opdate |
PT Kalbe Farma |
Goedkeuring |
Glargine Insuline |
bGlargine, Semglee |
Jeast ( Pichia Pastoris ) |
Viatris, Biocon Groep, Mylan |
Goedkeuring |
Insulin aspart |
bAspart |
Jeast ( Pichia Pastoris ) |
Viatris, Mylan, Biocon Groep |
Goedkeuring |
Menslike Insuline, Rekombinant |
Inpremzia |
Jeast ( Pichia Pastoris ) |
Baxter, CELERITY PHARMS |
Goedkeuring |
Glargine Insuline, biosoortgelyk |
Wag opdate |
Jeast ( Pichia Pastoris ) |
HEC, Lannett |
Goedkeuring |
lispro+protamine insuline |
速秀霖® 25 |
Wag opdate |
Ganlee |
Goedkeuring |
Insulin aspart |
skerpshowlin |
Wag opdate |
Ganlee, Sandoz |
Goedkeuring |
Lispro Insulien |
vinnoshowlin |
Wag opdate |
Ganlee, Sandoz |
Goedkeuring |
Glargine Insuline |
langshowlin |
Wag opdate |
Ganlee, Sandoz |
Goedkeuring |
Menslike Insuline, Rekombinant |
Wag opdate |
Wag opdate |
Hefei Tianmai Biotechnology Development Co., Ltd. |
Goedkeuring |
Lispro Insulien |
Wag opdate |
Wag opdate |
Wanbang Biopharma |
Goedkeuring |
Menslike Insuline, Rekombinant |
Wag opdate |
Wag opdate |
Wanbang Biopharma |
Goedkeuring |
Glargine Insuline |
Wag opdate |
Wag opdate |
Wanbang Biopharma, Fosun Pharma |
Goedkeuring |
Menslike Insuline, Rekombinant |
uitsling |
Pichia Pastoris |
The United Laboratories International Holdings Limited (TUL) |
Goedkeuring |
Glargine Insuline |
Wag opdate |
Wag opdate |
MSD, Samsung Bioepis |
Goedkeuring |
Insulin aspart |
skerp suur |
Wag opdate |
Tonghua Dongbao Geneesmiddels |
Goedkeuring |
Glargine Insuline |
Glargine insuline biosimilars (THTB), Vlak suur |
Wag opdate |
Tonghua Dongbao Geneesmiddels |
Goedkeuring |
Recombinant menslike insulien |
Wag opdate |
Wag opdate |
Tonghua Dongbao Geneesmiddels |
Goedkeuring |
Glargine Insuline |
Wag opdate |
Wag opdate |
WOCKHARDT |
Goedkeuring |
mecasermin |
INCRELEX |
Escherichia Coli |
IPSEN, Genentech, Tercica |
Goedkeuring |
Insulin aspart |
Wag opdate |
Wag opdate |
Zhejiang Hisun Geneesmiddelkundige Maatskappy Ltd |
Goedkeuring |
Glargine Insuline |
Wag opdate |
Escherichia Coli |
Chongqing Fujin, Lunan Geneesmiddels |
Goedkeuring |
Insulin aspart |
uitstekende beweeglikheid |
Heuninggist |
The United Laboratories International Holdings Limited (TUL) |
Goedkeuring |
Glargine Insuline |
uitstekende vreugde |
Wag opdate |
The United Laboratories International Holdings Limited (TUL) |
Goedkeuring |
Insulien prandiale spuitbare |
Linjeta, VIAject |
Wag opdate |
Albireo Pharma, Biodel |
Indien vir goedkeuring |
Insuline lispro |
GP40191 |
Wag opdate |
Geropharm |
Indien vir goedkeuring |
Insulin Glargine |
GP40201 |
Wag opdate |
Geropharm |
Indien vir goedkeuring |
insulien |
Biosoortgelyk |
Wag opdate |
Marvel Lifesciences Ltd |
Indien vir goedkeuring |
Insuline+Protamine Insuline |
Biosoortgelyk |
Wag opdate |
HEC |
Indien vir goedkeuring |
Glargine Insuline |
Biosoortgelyk |
Wag opdate |
Hefei Tianmai Biotechnology |
Indien vir goedkeuring |
insulin degludec |
Biosoortgelyk |
Wag opdate |
Jilin Jinsheng, Huisheng Pharm, Hainan Sihuan Pharmaceutical, PEG-BIO Biopharm |
Indien vir goedkeuring |
lispro+protamine insuline |
Biosoortgelyk |
Wag opdate |
Wanbang Biopharma, Fosun Pharma |
Indien vir goedkeuring |
insuline lispro |
LY900014 |
Wag opdate |
Eli Lilly |
Indien vir goedkeuring |
Glargine Insuline |
Biosoortgelyk |
Wag opdate |
Liaoning Boao Bio Pharmaceutical, Lepu Medicdal |
Indien vir goedkeuring |
Insulin aspart |
Biosoortgelyk |
Wag opdate |
Hainan Sihuan Pharmaceutical, Huisheng Pharm |
Indien vir goedkeuring |
insulin aspart protamine + insulin aspart |
Biosoortgelyk |
Wag opdate |
Hainan Sihuan Pharmaceutical, Huisheng Pharm |
Indien vir goedkeuring |
insulin degludec |
Biosoortgelyk |
Wag opdate |
Hainan Sihuan Pharmaceutical, Huisheng Pharm |
Indien vir goedkeuring |
Insulin aspart |
Biosoortgelyk |
Wag opdate |
Hainan Sihuan Pharmaceutical, Huisheng Pharm |
Indien vir goedkeuring |
Icodec Insulin/NN9535 |
Wag opdate |
Wag opdate |
Novo Nordisk |
Fase III |
Insuline icodec |
IA287, qw Voorbereiding |
Heuninggist |
Novo Nordisk |
Fase III |
Basale insuline-Fc |
Basale insuline-Fc, BIF, LY-3209590, LY 3209590, LY3209590 |
CHO-sel |
Eli Lilly en Kompagnie |
Fase III |
Insulin Glargine |
HOE901-U300 |
Wag opdate |
Sanofi |
Fase III |
Exubera |
Ingeademde insulien, van die lys af |
Wag opdate |
Pfizer, Sanofi, Nektar Therapeutics |
Fase III |
Insuliëen tregopil |
Wag opdate |
Wag opdate |
Biocon Group |
Fase III |
ELGN-2112 |
Wag opdate |
Wag opdate |
Elgan Pharma |
Fase III |
ELGN-2112 |
Wag opdate |
Wag opdate |
Elgan Pharma |
Fase III |
Mondingspuit insulien |
Wag opdate |
Wag opdate |
Generex Biotechnology |
Fase III |
insulien |
Wag opdate |
Wag opdate |
MannKind Corporation |
Fase III |
Subetta |
n geneesmiddel wat vrygestelde aktiewe vorms van antilowe teen die insuliënomvanger β-subeenheid en antilowe teen endoteliale stikstofmonoksied-sintase bevat |
Wag opdate |
Materia Medica Holding |
Fase III |
Oral Insulin-NTRA-2112 |
Orale |
Wag opdate |
Nutrinia |
Fase III |
Intranasale insulien |
Wag opdate |
Wag opdate |
Panamerican Universiteit |
Fase III |
insulin aspart protamine + insulin aspart |
Wag opdate |
Wag opdate |
SL Pharm |
Fase III |
insulin degludec |
Wag opdate |
Wag opdate |
HEC |
Fase III |
Insulin Degludec+Insulin Aspart |
Wag opdate |
Wag opdate |
HEC |
Fase III |
Insulin Degludec+Insulin Aspart |
Wag opdate |
Wag opdate |
Huisheng Pharm, Hainan Sihuan Pharmaceutical Co., ltd |
Fase III |
insulin aspart protamine + insulin aspart |
Wag opdate |
Wag opdate |
Jilin JINsheng |
Fase III |
INS068 |
Wag opdate |
Wag opdate |
Jiangsu Hengrui Geneesmiddele, Luzsana Biotehnologie, Chengdu Shengdi |
Fase III |
insulien |
Wag opdate |
Wag opdate |
Merck, Merck Sharp & Dohme |
Fase III |
insulin degludec |
Wag opdate |
Wag opdate |
Bovaxbio, Chenan Biopharm |
Fase III |
Insulin Degludec+Insulin Aspart |
Wag opdate |
Wag opdate |
Hainan Sihuan Geneesmiddele Co., ltd, Huisheng Pharm |
Fase III |
Insuline+Protamine Insuline |
Wag opdate |
Wag opdate |
Hainan Sihuan Geneesmiddele Co., ltd, Huisheng Pharm |
Fase III |
Protamine Insuline |
Wag opdate |
Wag opdate |
Hainan Sihuan Pharmaceutical, Huisheng Pharm |
Fase III |
lispro+protamine insuline |
Wag opdate |
Wag opdate |
Tonghua Dongbao Geneesmiddels |
Fase III |
BC Lispro-THDB0206 |
Ultra-Snellwerkende BC Lispro |
Wag opdate |
Tonghua Dongbao Geneesmiddele, Adocia |
Fase III |
Insuline darmbedekkingspille |
Wag opdate |
Wag opdate |
FOSSE BIO, Tsinghua Universiteit |
Fase III |
Orale insuline-ORMD-0801 |
Orale insuline-ORMD-0801 (PODTM) |
Wag opdate |
Oramed Pharmaceuticals |
Fase III |
Menslike insulien |
Wag opdate |
Wag opdate |
Zhejiang Hisun Geneesmiddelkundige Maatskappy Ltd |
Fase III |
Glargine Insuline |
Wag opdate |
Wag opdate |
Zhejiang Hisun Geneesmiddelkundige Maatskappy Ltd |
Fase III |
insulin degludec |
Wag opdate |
Wag opdate |
CTTQ Pharma |
Fase III |
insulin degludec |
Wag opdate |
Wag opdate |
The United Laboratories International Holdings Limited (TUL) |
Fase III |
Insuline intranasaal |
Intranasale insulien |
Wag opdate |
Adhera Therapeutics, MDRNA |
Fase II |
Insuline Lispro+Pramlintide |
Samestellings-Vermyding |
Wag opdate |
Adocia |
Fase II |
ingesogde insulien-AER 501 |
Ingesogde insulien |
Wag opdate |
Aerami Therapeutics |
Fase II |
BIOD-123 |
Nuwe formulering, Snel-aanset |
Wag opdate |
Albireo Pharma, Biodel |
Fase II |
intranasale insulien |
Intranasale insulien |
Wag opdate |
Biocon Groep, Cpex Pharmaceuticals |
Fase II |
HDV Insulien Lispro |
Voorbereiding |
Wag opdate |
Diasome Pharmaceuticals |
Fase II |
Lispro-PH20 |
Subkutane geneesmiddeltoediening |
Wag opdate |
Halozyme Therapeutics |
Fase II |
Aspart-PH20 |
Wag opdate |
Wag opdate |
Halozyme Therapeutics |
Fase II |
Insulin338 |
Mondinglike insulien |
Wag opdate |
Merrion Pharmaceuticals, Novo Nordisk |
Fase II |
Mondinglike insulien |
Orale |
Wag opdate |
Oshadi Geneesmiddeltoediening |
Fase II |
Super-Lange-Werkende Basale Insulien-PE0139 |
Super-Lang-Werkend, fusions eiwit |
Wag opdate |
PhaseBio Pharmaceuticals |
Fase II |
Pramlintide+ insulien |
XP3924 |
Wag opdate |
Xeris Pharmaceuticals |
Fase II |
BMS-754807 |
Wag opdate |
Wag opdate |
Bristol Myers Squibb |
Fase II |
Verbindings: basis langwerkende insulien+GLP-1 |
HR17031 |
Wag opdate |
Jiangsu Hengrui Pharmaceuticals Co., Ltd |
Fase II |
Insulien Glargine+Insulien Lispro |
BC Combo THDB 0207, BioChaperone Combo |
Wag opdate |
Tonghua Dongbao Pharmaceutical Co., Ltd, Adocia |
Fase II |